02/11/2017 - 06:49

MGC to supply marijuana products for epilepsy sufferers

02/11/2017 - 06:49

Bookmark

Upgrade your subscription to use this feature.

Whilst most other medical marijuana companies are still trying to work out how to make money, ASX-listed MGC Pharmaceuticals are busy collecting purchase orders for their cannabis based products.
The company has signed a binding heads of agreement with local pharmaceutical distributor, HL Pharma to distribute MGC's low cost, cannabis based epilepsy drug CannEpil in Australia.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options